JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL.
Saleem SK, Decker S, Kissel S, Bauer M, Chernyakov D, Bräuer-Hartmann D, Aumann K, Wickenhauser C, Herling M, Skorobohatko O, Mathew N, Schmidt C, Klein C, Follo M, Dierks C.
Saleem SK, et al.
J Exp Med. 2025 Jan 6;222(1):e20230681. doi: 10.1084/jem.20230681. Epub 2024 Nov 21.
J Exp Med. 2025.
PMID: 39570282